Effects of a Novel Palatinose Based Enteral Formula (MHN-01) Carbohydrate-Adjusted Fluid Diet in Improving the Metabolism of Carbohydrates and Lipids in Patients with Esophageal Cancer Complicated by Diabetes Mellitus

Toshiya Fujiwara, Yoshio Naomoto, Takayuki Motoki, Kaori Shigemitsu, Yasuhiro Shirakawa, Tomoki Yamatsuji, Masafumi Kataoka, Minoru Haisa, Toshiyoshi Fujiwara, Maritoki Egi, Hiroshi Morimatsu, Motohiko Hanazaki, Hiroshi Katayama, Kiyoshi Morita, Kenji Mizumoto, Takanobu Asou, Hirofumi Arima, Hajime Sasaki, Motoi Matsuura, Mehmet GunduzNoriaki Tanaka

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: During perioperative management of patients with gastrointestinal cancer complicated by diabetes mellitus, adequate alimentation is required, but we often face difficulties associated with hyperglycemia and other accompanying complications. Recently, we investigated the effects of a novel palatinose based enteral formula (MHN-01) in suppressing post-prandial hyperglycemia and improving lipid metabolism in experimental animals and perioperative management of patients with esophageal cancer complicated by diabetes mellitus. Materials and methods: We gave normal rats and rats with type 2 diabetes mellitus a single oral dose of fluid diet, and analyzed comparatively the time course of blood glucose level in each group until 3 h after the dose. In both the normal rat group and the type 2 diabetes group, peak blood glucose level after the MHN-01 dose was significantly lower than after a dose of ordinary fluid diet and was comparable to the peak level after a dose of a fluid diet rich in MUFA (monounsaturated fatty acid). We allowed normal mice free access to fluid diet for 43 days, and measured their body fat levels. Fat accumulation was significantly lower in mice given MHN-01 than in mice given ordinary fluid diet. We also analyzed the respiratory quotient and resting energy expenditure of normal Sprague-Dawley rats fed by MHN-01 or an ordinary fluid diet. The respiratory quotient of the MHN-01 group was significantly lower than the ordinary fluid group, although the resting energy expenditure of both groups was almost the same level. The effect of MHN-01 was estimated to be based on improvement of lipid metabolism. Results: Between 2003 and 2005, among 164 patients who underwent radical thoracic esophagectomy and/or reconstruction for esophageal carcinoma at Okayama University Hospital, nine patients (5.5%) were diagnosed with diabetes mellitus in pre-operative screening and were treated with MHN-01. Clinical courses of two cases with severe status of diabetes mellitus were presented as successful case reports of MHN-01. Conclusion: MHN-01 was very useful in perioperative management of patients complicated by diabetes mellitus, unable to ingest food p.o. such as esophageal cancer or other diseases.

Original languageEnglish
Pages (from-to)231-240
Number of pages10
JournalJournal of Surgical Research
Volume138
Issue number2
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Carbohydrate Metabolism
Esophageal Neoplasms
Lipid Metabolism
Small Intestine
Diabetes Mellitus
Carbohydrates
Diet
Hyperglycemia
Type 2 Diabetes Mellitus
Energy Metabolism
Blood Glucose
Monounsaturated Fatty Acids
Gastrointestinal Neoplasms
Esophagectomy
Sprague Dawley Rats
Meals
isomaltulose
Adipose Tissue
Thorax
Fats

Keywords

  • diabetes
  • esophageal cancer
  • MHN-01
  • perioperative hyperglycemia

ASJC Scopus subject areas

  • Surgery

Cite this

Effects of a Novel Palatinose Based Enteral Formula (MHN-01) Carbohydrate-Adjusted Fluid Diet in Improving the Metabolism of Carbohydrates and Lipids in Patients with Esophageal Cancer Complicated by Diabetes Mellitus. / Fujiwara, Toshiya; Naomoto, Yoshio; Motoki, Takayuki; Shigemitsu, Kaori; Shirakawa, Yasuhiro; Yamatsuji, Tomoki; Kataoka, Masafumi; Haisa, Minoru; Fujiwara, Toshiyoshi; Egi, Maritoki; Morimatsu, Hiroshi; Hanazaki, Motohiko; Katayama, Hiroshi; Morita, Kiyoshi; Mizumoto, Kenji; Asou, Takanobu; Arima, Hirofumi; Sasaki, Hajime; Matsuura, Motoi; Gunduz, Mehmet; Tanaka, Noriaki.

In: Journal of Surgical Research, Vol. 138, No. 2, 04.2007, p. 231-240.

Research output: Contribution to journalArticle

Fujiwara, T, Naomoto, Y, Motoki, T, Shigemitsu, K, Shirakawa, Y, Yamatsuji, T, Kataoka, M, Haisa, M, Fujiwara, T, Egi, M, Morimatsu, H, Hanazaki, M, Katayama, H, Morita, K, Mizumoto, K, Asou, T, Arima, H, Sasaki, H, Matsuura, M, Gunduz, M & Tanaka, N 2007, 'Effects of a Novel Palatinose Based Enteral Formula (MHN-01) Carbohydrate-Adjusted Fluid Diet in Improving the Metabolism of Carbohydrates and Lipids in Patients with Esophageal Cancer Complicated by Diabetes Mellitus', Journal of Surgical Research, vol. 138, no. 2, pp. 231-240. https://doi.org/10.1016/j.jss.2006.06.025
Fujiwara, Toshiya ; Naomoto, Yoshio ; Motoki, Takayuki ; Shigemitsu, Kaori ; Shirakawa, Yasuhiro ; Yamatsuji, Tomoki ; Kataoka, Masafumi ; Haisa, Minoru ; Fujiwara, Toshiyoshi ; Egi, Maritoki ; Morimatsu, Hiroshi ; Hanazaki, Motohiko ; Katayama, Hiroshi ; Morita, Kiyoshi ; Mizumoto, Kenji ; Asou, Takanobu ; Arima, Hirofumi ; Sasaki, Hajime ; Matsuura, Motoi ; Gunduz, Mehmet ; Tanaka, Noriaki. / Effects of a Novel Palatinose Based Enteral Formula (MHN-01) Carbohydrate-Adjusted Fluid Diet in Improving the Metabolism of Carbohydrates and Lipids in Patients with Esophageal Cancer Complicated by Diabetes Mellitus. In: Journal of Surgical Research. 2007 ; Vol. 138, No. 2. pp. 231-240.
@article{4ab8096136fe449587151868c229f60c,
title = "Effects of a Novel Palatinose Based Enteral Formula (MHN-01) Carbohydrate-Adjusted Fluid Diet in Improving the Metabolism of Carbohydrates and Lipids in Patients with Esophageal Cancer Complicated by Diabetes Mellitus",
abstract = "Background: During perioperative management of patients with gastrointestinal cancer complicated by diabetes mellitus, adequate alimentation is required, but we often face difficulties associated with hyperglycemia and other accompanying complications. Recently, we investigated the effects of a novel palatinose based enteral formula (MHN-01) in suppressing post-prandial hyperglycemia and improving lipid metabolism in experimental animals and perioperative management of patients with esophageal cancer complicated by diabetes mellitus. Materials and methods: We gave normal rats and rats with type 2 diabetes mellitus a single oral dose of fluid diet, and analyzed comparatively the time course of blood glucose level in each group until 3 h after the dose. In both the normal rat group and the type 2 diabetes group, peak blood glucose level after the MHN-01 dose was significantly lower than after a dose of ordinary fluid diet and was comparable to the peak level after a dose of a fluid diet rich in MUFA (monounsaturated fatty acid). We allowed normal mice free access to fluid diet for 43 days, and measured their body fat levels. Fat accumulation was significantly lower in mice given MHN-01 than in mice given ordinary fluid diet. We also analyzed the respiratory quotient and resting energy expenditure of normal Sprague-Dawley rats fed by MHN-01 or an ordinary fluid diet. The respiratory quotient of the MHN-01 group was significantly lower than the ordinary fluid group, although the resting energy expenditure of both groups was almost the same level. The effect of MHN-01 was estimated to be based on improvement of lipid metabolism. Results: Between 2003 and 2005, among 164 patients who underwent radical thoracic esophagectomy and/or reconstruction for esophageal carcinoma at Okayama University Hospital, nine patients (5.5{\%}) were diagnosed with diabetes mellitus in pre-operative screening and were treated with MHN-01. Clinical courses of two cases with severe status of diabetes mellitus were presented as successful case reports of MHN-01. Conclusion: MHN-01 was very useful in perioperative management of patients complicated by diabetes mellitus, unable to ingest food p.o. such as esophageal cancer or other diseases.",
keywords = "diabetes, esophageal cancer, MHN-01, perioperative hyperglycemia",
author = "Toshiya Fujiwara and Yoshio Naomoto and Takayuki Motoki and Kaori Shigemitsu and Yasuhiro Shirakawa and Tomoki Yamatsuji and Masafumi Kataoka and Minoru Haisa and Toshiyoshi Fujiwara and Maritoki Egi and Hiroshi Morimatsu and Motohiko Hanazaki and Hiroshi Katayama and Kiyoshi Morita and Kenji Mizumoto and Takanobu Asou and Hirofumi Arima and Hajime Sasaki and Motoi Matsuura and Mehmet Gunduz and Noriaki Tanaka",
year = "2007",
month = "4",
doi = "10.1016/j.jss.2006.06.025",
language = "English",
volume = "138",
pages = "231--240",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of a Novel Palatinose Based Enteral Formula (MHN-01) Carbohydrate-Adjusted Fluid Diet in Improving the Metabolism of Carbohydrates and Lipids in Patients with Esophageal Cancer Complicated by Diabetes Mellitus

AU - Fujiwara, Toshiya

AU - Naomoto, Yoshio

AU - Motoki, Takayuki

AU - Shigemitsu, Kaori

AU - Shirakawa, Yasuhiro

AU - Yamatsuji, Tomoki

AU - Kataoka, Masafumi

AU - Haisa, Minoru

AU - Fujiwara, Toshiyoshi

AU - Egi, Maritoki

AU - Morimatsu, Hiroshi

AU - Hanazaki, Motohiko

AU - Katayama, Hiroshi

AU - Morita, Kiyoshi

AU - Mizumoto, Kenji

AU - Asou, Takanobu

AU - Arima, Hirofumi

AU - Sasaki, Hajime

AU - Matsuura, Motoi

AU - Gunduz, Mehmet

AU - Tanaka, Noriaki

PY - 2007/4

Y1 - 2007/4

N2 - Background: During perioperative management of patients with gastrointestinal cancer complicated by diabetes mellitus, adequate alimentation is required, but we often face difficulties associated with hyperglycemia and other accompanying complications. Recently, we investigated the effects of a novel palatinose based enteral formula (MHN-01) in suppressing post-prandial hyperglycemia and improving lipid metabolism in experimental animals and perioperative management of patients with esophageal cancer complicated by diabetes mellitus. Materials and methods: We gave normal rats and rats with type 2 diabetes mellitus a single oral dose of fluid diet, and analyzed comparatively the time course of blood glucose level in each group until 3 h after the dose. In both the normal rat group and the type 2 diabetes group, peak blood glucose level after the MHN-01 dose was significantly lower than after a dose of ordinary fluid diet and was comparable to the peak level after a dose of a fluid diet rich in MUFA (monounsaturated fatty acid). We allowed normal mice free access to fluid diet for 43 days, and measured their body fat levels. Fat accumulation was significantly lower in mice given MHN-01 than in mice given ordinary fluid diet. We also analyzed the respiratory quotient and resting energy expenditure of normal Sprague-Dawley rats fed by MHN-01 or an ordinary fluid diet. The respiratory quotient of the MHN-01 group was significantly lower than the ordinary fluid group, although the resting energy expenditure of both groups was almost the same level. The effect of MHN-01 was estimated to be based on improvement of lipid metabolism. Results: Between 2003 and 2005, among 164 patients who underwent radical thoracic esophagectomy and/or reconstruction for esophageal carcinoma at Okayama University Hospital, nine patients (5.5%) were diagnosed with diabetes mellitus in pre-operative screening and were treated with MHN-01. Clinical courses of two cases with severe status of diabetes mellitus were presented as successful case reports of MHN-01. Conclusion: MHN-01 was very useful in perioperative management of patients complicated by diabetes mellitus, unable to ingest food p.o. such as esophageal cancer or other diseases.

AB - Background: During perioperative management of patients with gastrointestinal cancer complicated by diabetes mellitus, adequate alimentation is required, but we often face difficulties associated with hyperglycemia and other accompanying complications. Recently, we investigated the effects of a novel palatinose based enteral formula (MHN-01) in suppressing post-prandial hyperglycemia and improving lipid metabolism in experimental animals and perioperative management of patients with esophageal cancer complicated by diabetes mellitus. Materials and methods: We gave normal rats and rats with type 2 diabetes mellitus a single oral dose of fluid diet, and analyzed comparatively the time course of blood glucose level in each group until 3 h after the dose. In both the normal rat group and the type 2 diabetes group, peak blood glucose level after the MHN-01 dose was significantly lower than after a dose of ordinary fluid diet and was comparable to the peak level after a dose of a fluid diet rich in MUFA (monounsaturated fatty acid). We allowed normal mice free access to fluid diet for 43 days, and measured their body fat levels. Fat accumulation was significantly lower in mice given MHN-01 than in mice given ordinary fluid diet. We also analyzed the respiratory quotient and resting energy expenditure of normal Sprague-Dawley rats fed by MHN-01 or an ordinary fluid diet. The respiratory quotient of the MHN-01 group was significantly lower than the ordinary fluid group, although the resting energy expenditure of both groups was almost the same level. The effect of MHN-01 was estimated to be based on improvement of lipid metabolism. Results: Between 2003 and 2005, among 164 patients who underwent radical thoracic esophagectomy and/or reconstruction for esophageal carcinoma at Okayama University Hospital, nine patients (5.5%) were diagnosed with diabetes mellitus in pre-operative screening and were treated with MHN-01. Clinical courses of two cases with severe status of diabetes mellitus were presented as successful case reports of MHN-01. Conclusion: MHN-01 was very useful in perioperative management of patients complicated by diabetes mellitus, unable to ingest food p.o. such as esophageal cancer or other diseases.

KW - diabetes

KW - esophageal cancer

KW - MHN-01

KW - perioperative hyperglycemia

UR - http://www.scopus.com/inward/record.url?scp=33847650558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847650558&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2006.06.025

DO - 10.1016/j.jss.2006.06.025

M3 - Article

C2 - 17254607

AN - SCOPUS:33847650558

VL - 138

SP - 231

EP - 240

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -